ALGT has given back ground this week, falling 5.5% to $111.14, yet the analyst community is still moving its targets higher — a divergence between short-term price action and a Street that continues to re-rate the name.
The pace of fresh analyst activity is striking. Barclays reinstated coverage on Tuesday with an Overweight and a $145 target. Melius Research upgraded to Buy the same day, setting a $160 objective. Both moves follow JP Morgan's Overweight initiation at $156 last week and Goldman Sachs lifting its Buy target from $125 to $142 earlier in the month. Morgan Stanley, still at Equal-Weight, raised its target from $100 to $115. Susquehanna maintained Neutral but pushed its target from $85 to $132. The direction of travel is almost uniformly upward, even from the sceptics. The mean target now rests near $135 — a 21% premium to where the stock closed Tuesday. That gap has widened meaningfully from last week, when the previous note flagged that consensus had barely kept pace with the share price. The stock has since pulled back and the targets have kept rising, so the discount to consensus is now genuine rather than nominal.
Short interest adds a layer of complexity. Bears hold roughly 10% of the free float — a meaningful position that has grown 64% over the past month, roughly doubling from around 1 million shares short in early June to 1.76 million today. The week-on-week move is modest, down about 1.3%, suggesting the short build has paused rather than reversed. Importantly, the borrow market offers no squeeze pressure to speak of: availability is running near 1,930% — far above the 52-week floor of 287% — meaning shares to borrow are abundant relative to existing shorts. Cost to borrow is a negligible 0.50%, up 12% on the week but still essentially free to borrow. Short sellers are not crowded out of their trades; they simply disagree with the bulls at a low carrying cost.
Options positioning has eased from the more defensive readings seen earlier in the week. The put/call ratio dropped to 0.76 on Tuesday from 0.89 Monday, moving back toward its 20-day average of 0.72. The z-score of 0.32 puts current positioning well within normal range — neither notably defensive nor aggressively bullish. Peers moved with ALGT on the week: ALK dropped 5.5%, UAL fell 5.1%, and DAL shed 4.9%, suggesting the week's pullback is sector-wide rather than ALGT-specific.
Institutional ownership data shows BlackRock added 556,000 shares in June, bringing its stake to 7.8% of shares outstanding. American Century added 448,000 shares through late May. Both additions came during the sharp re-rating, indicating at least some institutional conviction behind the move. The ORTEX short score of 43.7 sits in the 32nd percentile — below the midpoint — consistent with a name where short pressure is present but not dominant. The factor picture is more interesting on the analyst side: the analyst recommendation differential ranks in the 99th percentile, an unusually wide gap between current consensus and the prior period's positioning.
Q2 results are due July 31. The last print in late April produced a muted one-day reaction of +0.7%, followed by a 10% five-day gain. The February print generated a 7% one-day move and a 18% five-day move. How much of the current analyst optimism is already priced into the $111 handle — versus what the earnings release itself might deliver — is the question the next three weeks will answer.
See the live data behind this article on ORTEX.
Open ALGT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
